Posts Tagged ‘by Amanda Conschafter – blog editor’

Access Worries Persist after ICER’s Arthritis Report, Meeting

A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients. The

Read More

Can the Gas Company’s Model Help Seniors Manage Rx Co-pays?

Senior citizens can face crippling out-of-pocket costs for their Medicare Part D prescription drugs. But now the University of Pennsylvania’s Perelman School of Medicine has

Read More

Cardiac Meds Cut Patients’ Heart Attack Risk – Or Your Money Back

Cholesterol-lowering drugs known as PCSK9 inhibitors can reduce the risk of heart, stroke and cardiovascular death by 20 percent, new research confirms.  And if patients

Read More

How a Human Milk Diet Protects Premature Infants

“Breast is best” is familiar advice for new mothers and infant health care providers.  But what about mothers of preemies, who often struggle to produce

Read More

Poor & Black Children Bear the Brunt of Asthma, Research Confirms

More than 6 million children in the United States suffer from asthma. But several new studies paint a startling picture of how this disease impacts

Read More

HHS Reports Tout Value of Hepatitis C Treatment, Screening

Two new publications point to the value of treating hepatitis C – early, aggressively and alongside heightened screening efforts. Expert Consultation Report The Department of

Read More

New Opioid Guidelines, Same Coverage Quandry

New pain treatment guidelines underscore a now familiar disconnect: the gap between what patients need and what their health plans will pay for. The American

Read More

Rare Disease Day Spotlights Need for Research

Rare Disease Day brings international attention to the plight of patients who struggle with ALS, Gaucher disease, cystic fibrosis and other less common conditions.  This

Read More

New Cystic Fibrosis Group Weighs in on Obamacare Revamp

As Congress continues to debate the future of the Affordable Care Act, a new advocacy group has a message for key legislators: protect cystic fibrosis

Read More

Does ICER Model Work for Rheumatoid Arthritis Treatments?

The Institute for Clinical and Economic Review’s newest cost-effectiveness report underscores just how far economic modeling sometimes diverges from patients’ reality, explained the Institute for

Read More
Back to Top